Ascletis Selects a Next-Generation Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development
- In head-to-head non-human primate (NHP) studies, average observed half-life of ASC37 was approximately 17 days, 7-fold longer than retatrutide, which supports once-monthly subcutaneous (SQ) dosing in humans. - ASC37's average in vitro activity was...
A Strategic Milestone: PhotonPay Secures U.S. MTL License to Anchor Its Global Regulatory Framework
HONG KONG, Jan. 19, 2026 /PRNewswire/ -- PhotonPay, a leading global digital financial infrastructure platform, has obtained Money Transmitter License (MTL) from state financial regulatory authority in the United States. Through the successful...
FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to iRegene's NouvNeu001, Making It the World's First iPSC Therapy with Both FTD and RMAT Recognitions
Designation underscores potential of chemically induced, off-the-shelf cell therapy to address high unmet need in Parkinson's disease, following compelling Phase I clinical data CHENGDU, China, Jan. 19, 2026 /PRNewswire/ -- iRegene Therapeutics Co.,...
USI Subsidiary Universal Optoelectronics Acquires Controlling Stake in Eugenlight Technologies, Advancing Optical Interconnect Industry Integration
SHANGHAI, Jan. 16, 2026 /PRNewswire/ -- USI announces that its wholly-owned subsidiary, Universal Optoeletronics Co., Ltd., completed the acquisition of a controlling stake in EugenLight Technologies. USI Subsidiary Universal Optoelectronics...
Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs
SHANGHAI and HONG KONG, Jan. 16, 2026 /PRNewswire/ -- Antengene Corporation Limited (" Antengene ", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...
Shoucheng Holdings (0697.HK) Pioneers Investor-Led Livestream Commerce, Advancing End-to-End Commercialization of Its Robotics Ecosystem
HONG KONG, Jan. 15, 2026 /PRNewswire/ -- As the robotics industry accelerates its transition toward large-scale commercialization, Shoucheng Holdings (0697.HK) has announced another significant milestone in its robotics investment and...
Head-to-Head Real-World dаta: Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer
HONG KONG, Jan. 14, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced the presentation of a real-world study at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI), comparing cadonilimab plus chemotherapy...
ApexVision Debuts at CES 2026: Guide Sensmart Ushers in the Ultra-Clarity Era of Thermal Imaging
LAS VEGAS, Jan. 9, 2026 /PRNewswire/ -- Guide Sensmart (Booth 21740, Central Hall), a global leader in thermal imaging technology, officially launched its next-generation thermal imaging innovation – ApexVision – alongside a series of new products...
Ribo Life Science (06938.HK) Successfully Lists on the Main Board of the Hong Kong Stock Exchange
HONG KONG, Jan. 9, 2026 /PRNewswire/ -- Ribo Life Science Co., Ltd. ("Ribo" or the "Company", stock code: 06938.HK), a leading company in small interfering RNA (siRNA) therapeutics, today successfully listed on the Main Board of Hong Kong Stock...
From Quantified Meditation to Bio-Computing, All Here Launches the Bio-Intelligence Initiative
GENEVA, Jan. 8, 2026 /PRNewswire/ -- All Here announces the launch of the Bio-Intelligence Initiative, the world's first research program exploring how deep meditative states of stability and silence of Mind give rise to measurable neural patterns,...